San Jose Mercury News: Not long after he was diagnosed with ALS, Jim Barber clung to a small dose of hope: The East Bay resident became eligible to enter a 5-year-long clinical trial for a drug that sought to slow the progression of the incurable neurodegenerative, life-sapping disease.
The most significant government policy, business, and technology news and analysis delivered to your inbox.
Subscribe Nowi360Gov is an intelligent network of websites and e-newsletters that provides government business, policy and technology leaders with a single destination for the most important news and analysis regarding their agency strategies and initiatives.
Telephone: 202.760.2280
Toll Free: 855.i360.Gov
Fax: 202.697.5045
The most significant government policy, business, and technology news and analysis delivered to your inbox.
Subscribe Now